Insulet Corporation (NASDAQ:PODD)
Industry: Healthcare

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Its Omnipod System comprise two devices: a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, and its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.

Current Quote*
Last: $208.300
Change: 2.340
Book: $23.159
Volume: 114,513

As Of: 08/13 12:45 ET
*Quotes delayed by 20min.

Graphs for PODD


3 Month Graph


6 Month Graph


1 Year Graph